Literature DB >> 20724593

tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

Ling Lin1, Guojun Bu, Wendy M Mars, W Brian Reeves, Sakae Tanaka, Kebin Hu.   

Abstract

In renal fibrosis, interstitial fibroblasts have an increased proliferative phenotype, and the numbers of interstitial fibroblasts closely correlate with the extent of kidney damage. The mechanisms underlying proliferation and resulting expansion of the interstitium remain largely unknown. Here we define the intracellular signaling events by which tissue plasminogen activator (tPA) promotes renal interstitial fibroblast proliferation. tPA promoted the proliferation of renal interstitial fibroblasts independent of its protease activity. The mitogenic effect of tPA required Tyr(4507) phosphorylation of the cytoplasmic tail of its receptor LDL receptor-related protein 1. tPA triggered sequential proliferative signaling events involving Erk1/2, p90RSK, GSK3β phosphorylation, and cyclin D1 induction. Blockade of Erk1/2 activation or knockdown of p90RSK suppressed tPA-induced GSK3β phosphorylation, cyclin D1 expression, and fibroblast proliferation. In contrast, expression of constitutively active Mek1 mimicked tPA in inducing GSK3β phosphorylation and cyclin D1 expression. Ectopic overexpression of an uninhibitable GSK3β mutant eliminated tPA-induced cyclin D1 expression. In the murine obstruction model, tPA deficiency reduced renal GSK3β phosphorylation and induction of PCNA and FSP-1. These findings show that tPA induces Tyr(4507) phosphorylation of LDL receptor-related protein 1, which in turn leads to the downstream phosphorylation of Erk1/2, p90RSK, and GSK3β, followed by the induction of cyclin D1 in murine interstitial fibroblasts. This study implicates tPA as a mitogen that promotes interstitial fibroblast proliferation, leading to expansion of these cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724593      PMCID: PMC2947266          DOI: 10.2353/ajpath.2010.100213

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function betwenn LRP and the PDGF.

Authors:  Elena Loukinova; Sripriya Ranganathan; Sergey Kuznetsov; Natalia Gorlatova; Mary M Migliorini; Dmitri Loukinov; Paula G Ulery; Irina Mikhailenko; Daniel A Lawrence; Dudley K Strickland
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

Review 2.  Diverse roles for the LDL receptor family.

Authors:  Dudley K Strickland; Steven L Gonias; W Scott Argraves
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

Review 3.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

Review 4.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

5.  Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity.

Authors:  Yonehiro Kanemura; Hideki Mori; Satoshi Kobayashi; Omedul Islam; Eri Kodama; Atsuyo Yamamoto; Youko Nakanishi; Norio Arita; Mami Yamasaki; Hideyuki Okano; Masayuki Hara; Jun Miyake
Journal:  J Neurosci Res       Date:  2002-09-15       Impact factor: 4.164

6.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells.

Authors:  H Barnes; B Larsen; M Tyers; P van Der Geer
Journal:  J Biol Chem       Date:  2001-03-20       Impact factor: 5.157

8.  Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.

Authors:  S T Olson; R Swanson; D Day; I Verhamme; J Kvassman; J D Shore
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

9.  v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.

Authors:  Helen Barnes; Elizabeth J Ackermann; Peter van der Geer
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

10.  Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein.

Authors:  L M Obermoeller-McCormick; Y Li; H Osaka; D J FitzGerald; A L Schwartz; G Bu
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  18 in total

Review 1.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

3.  Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury.

Authors:  Meenalakshmi M Mariappan; Sanjay Prasad; Kristin D'Silva; Esteban Cedillo; Kavithalakshmi Sataranatarajan; Jeffrey L Barnes; Goutam Ghosh Choudhury; Balakuntalam S Kasinath
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

4.  The Ser/Thr kinase p90RSK promotes kidney fibrosis by modulating fibroblast-epithelial crosstalk.

Authors:  Ling Lin; Chaowen Shi; Zhaorui Sun; Nhat-Tu Le; Jun-Ichi Abe; Kebin Hu
Journal:  J Biol Chem       Date:  2019-05-10       Impact factor: 5.157

5.  Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways.

Authors:  Ling Lin; Yang Jin; Wendy M Mars; W Brian Reeves; Kebin Hu
Journal:  Am J Pathol       Date:  2014-08-12       Impact factor: 4.307

6.  Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathway.

Authors:  Ling Lin; Yang Jin; Kebin Hu
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

7.  Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.

Authors:  Ling Lin; Chuanyue Wu; Kebin Hu
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

8.  tPA regulates neurite outgrowth by phosphorylation of LRP5/6 in neural progenitor cells.

Authors:  Sung Hoon Lee; Hyun Myung Ko; Kyoung Ja Kwon; Jongmin Lee; Seol-Heui Han; Dong Wook Han; Jae Hoon Cheong; Jong Hoon Ryu; Chan Young Shin
Journal:  Mol Neurobiol       Date:  2013-08-08       Impact factor: 5.590

Review 9.  Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.

Authors:  Ling Lin; Kebin Hu
Journal:  Am J Clin Exp Immunol       Date:  2014-02-27

10.  Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.

Authors:  Keizo Kanasaki; Gangadhar Taduri; Daisuke Koya
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.